respiratori
syncyti
viru
rsv
import
caus
acut
respiratori
tract
infect
arti
neonat
young
children
rsv
infect
lead
bronchiol
pneumonia
fatal
especi
children
older
adult
risk
due
condit
like
prematur
birth
chronic
lung
diseas
congenit
heart
diseas
immun
defici
pediatrician
admit
child
arti
inpati
care
usual
unawar
underli
respiratori
pathogen
rapid
pointofcar
diagnost
tool
allow
time
identif
viral
pathogen
avail
sensit
rapid
rsv
test
critic
optim
care
manag
minim
unnecessari
antibiot
use
provid
target
infect
control
children
hospit
rsv
infect
major
limit
pointofcar
rsv
test
low
sensit
current
avail
rapid
antigen
detect
test
radt
gener
radt
sensit
strongli
depend
high
viral
load
respiratori
specimen
therefor
perform
best
young
infant
classic
symptom
rsv
bronchiol
pool
radt
sensit
confid
interv
ci
report
pediatr
patient
screen
popul
children
year
age
hospit
symptom
respiratori
tract
infect
observ
radt
sensit
ci
compar
revers
transcriptionpcr
rtpcr
adult
sensit
differ
radt
altern
radt
rapid
nucleic
acid
amplif
assay
develop
facilit
earli
recognit
rsv
infect
assay
provid
high
sensit
requir
test
time
least
h
aler
system
rapid
autom
vitro
diagnost
test
util
nick
enzym
amplif
reaction
platform
technolog
previous
develop
detect
influenza
viru
aler
influenza
provid
test
result
less
min
test
optim
pointofcar
set
requir
specif
train
experi
laboratori
techniqu
number
studi
evalu
rapid
influenza
test
comparison
viral
cultur
rtpcr
report
sensit
recent
platform
extend
test
cartridg
detect
streptococcu
aler
strep
rsv
aler
rsv
assay
introduc
routin
clinic
care
data
publish
regard
sensit
specif
novel
aler
rsv
test
object
studi
evalu
perform
aler
rsv
test
rapid
detect
rsv
children
hospit
acut
respiratori
tract
infect
total
nasopharyng
swab
np
sampl
includ
studi
test
aler
rsv
altona
realstar
rsv
rtpcr
three
sampl
aler
rsv
assay
invalid
lyophil
test
reagent
properli
dispens
due
handl
failur
sampl
exclud
analysi
remain
np
collect
patient
hospit
due
lower
respiratori
tract
infect
n
upper
respiratori
tract
infect
n
nonrespiratori
diagnos
includ
eg
febril
convuls
gastroenter
concomit
respiratori
tract
infect
n
patient
admiss
diagnosi
report
median
age
patient
includ
analysi
month
rang
week
year
altona
realstar
rsv
rtpcr
rsv
posit
rsv
neg
case
rsv
b
detect
rsvposit
sampl
respect
mean
threshold
cycl
ct
valu
rsvposit
sampl
ci
median
ct
valu
rang
mean
ct
valu
differ
rsv
rsv
bposit
sampl
rsv
rsv
b
p
aler
rsv
test
result
true
posit
sampl
true
neg
sampl
undertak
comprehens
analyt
specif
test
note
sampl
neg
altona
realstar
rsv
rtpcr
result
includ
sampl
previous
test
posit
influenza
n
influenza
b
n
parainfluenza
n
human
metapneumoviru
n
coronaviru
n
rhinoviru
n
parechoviru
n
adenoviru
n
sampl
diverg
test
result
test
result
interpret
fals
posit
wherea
test
result
invalid
due
sampl
interfer
fig
case
could
conduct
confirm
test
due
limit
sampl
volum
calcul
aler
rsv
specif
sampl
diverg
test
result
consid
fals
posit
thu
report
conserv
estim
aler
rsv
perform
combin
rsv
b
test
sensit
aler
rsv
ci
specif
aler
rsv
test
ci
tabl
aler
rsv
test
includ
step
preheat
lysi
buffer
follow
nick
enzym
amplif
reaction
maximum
durat
min
assay
identifi
posit
test
result
soon
amplif
threshold
reach
studi
median
durat
nick
enzym
amplif
reaction
rsvposit
sampl
min
rang
min
min
henc
rsvneg
sampl
total
durat
test
assay
min
min
preheat
plu
min
amplif
wherea
approxim
min
rsvposit
sampl
posit
test
result
identifi
quicker
sampl
high
viral
load
ct
valu
although
absolut
differ
small
probabl
minor
import
routin
care
fig
studi
found
novel
aler
rsv
assay
detect
rsv
infect
high
sensit
specif
np
sampl
obtain
children
hospit
acut
respiratori
tract
infect
result
deliv
within
min
posit
sampl
usual
identifi
within
min
assay
display
combin
posit
neg
test
result
rsv
b
without
provid
inform
rsv
subtyp
rsv
b
strain
reliabl
detect
test
assay
provid
clinician
confid
act
appropri
neg
aler
rsv
test
result
obtain
assay
requir
min
handson
time
experi
user
friendli
effici
although
initi
train
still
requir
obtain
invalid
test
result
due
handl
failur
transfer
sampl
eluat
lyophil
test
base
studi
two
limit
first
analysi
limit
term
sampl
size
conduct
np
collect
one
pediatr
hospit
singl
winter
season
aler
rsv
assay
perform
might
differ
set
particularli
sampl
lower
viral
load
consid
studi
result
therefor
necessarili
applic
adult
test
second
studi
use
frozen
sampl
laboratori
set
aler
rsv
test
intend
pointofcar
analysi
usual
conduct
clinic
rather
laboratori
set
corrobor
find
futur
studi
conduct
larger
patient
cohort
pointofcar
set
found
assay
easi
use
oper
guid
test
immedi
feedback
case
incorrect
handl
furthermor
retest
invalid
sampl
feasibl
analysi
usual
possibl
pointofcar
set
therefor
confid
result
report
analysi
repres
realist
estim
aler
rsv
test
perform
pediatr
patient
pointofcar
set
summari
novel
aler
rsv
assay
provid
highli
sensit
specif
test
result
less
min
advantag
consider
shorter
test
time
current
avail
molecular
test
assay
consider
higher
sensit
current
avail
radt
assay
aler
rsv
assay
could
becom
valuabl
tool
rapid
diagnosi
rsv
infect
pointofcar
set
winter
season
novemb
april
nasopharyng
swab
np
obtain
children
hospit
symptom
acut
respiratori
tract
infect
center
childhood
adolesc
medicin
heidelberg
germani
np
collect
ml
univers
transport
medium
articl
number
mswab
copan
brescia
itali
time
admiss
inpati
care
collect
np
specimen
refriger
within
h
aliquot
prepar
store
analys
demograph
clinic
inform
collect
prospect
physician
ask
specifi
diagnosi
admiss
ie
reason
hospit
base
clinic
judgment
diagnos
classifi
upper
respiratori
tract
infect
urti
includ
case
rhiniti
pharyng
otiti
media
croup
lower
respiratori
tract
infect
lrti
includ
case
bronchiti
bronchiol
pneumonia
admiss
diagnos
includ
among
other
case
febril
convuls
fever
unknown
origin
gastroenter
frozen
np
sampl
test
parallel
aler
rsv
versu
cecertifi
rtpcr
altona
realstar
rsv
pcr
kit
gold
standard
np
sampl
use
studi
thaw
aler
rsv
test
univers
transport
medium
contain
np
sampl
ad
sampl
receiv
contain
ml
elut
buffer
two
volum
transfer
test
base
isotherm
amplif
altona
realstar
rsv
pcr
assay
viral
rna
extract
univers
transport
medium
contain
np
sampl
elut
buffer
use
qiaamp
viral
rna
minikit
qiagen
hilden
germani
rna
elut
total
volum
transfer
altona
realstar
rsv
pcr
master
mix
rtpcr
result
ct
valu
consid
posit
aler
rsv
log
file
analyz
report
amplif
time
rsvposit
sampl
examin
sampl
invalid
test
result
sampl
invalid
test
result
due
kind
aler
rsv
test
handl
failur
exclud
analysi
contrast
sampl
invalid
test
result
due
sampl
interfer
consid
fals
neg
rtpcr
result
posit
fals
posit
rtpcr
refer
neg
possibl
reason
invalid
test
result
includ
inhibit
amplif
reaction
delay
amplif
sampl
low
viral
load
notabl
manufactur
recommend
retest
sampl
invalid
aler
rsv
result
howev
volum
respiratori
sampl
use
studi
limit
unabl
follow
recommend
statist
analys
conduct
use
statacorp
lp
colleg
station
tx
usa
student
test
use
compar
mean
ct
valu
rsv
aposit
versu
rsv
bposit
sampl
quadrat
predict
appli
visual
correl
aler
rsv
amplif
time
rtpcr
ct
valu
studi
approv
ethic
research
board
univers
hospit
heidelberg
germani
